This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Zhou Y, Zhang Y, Yang X, Fan L, Jiang J.Retrobulbar optic neuritis in a bevacizumab-treated patient with metastatic breast cancer. Breast Journal 18: 502-503, No. 5, Sep 2012. Available from: URL: http://dx.doi.org/10.1111/j.1524-4741.2012.01293.x - China
Optic-neuritis; adverse reactions; Bevacizumab; drug-induced; Docetaxel
An event is serious (FDA MedWatch definition) when the patient outcome is: death; life-threatening; hospitalisation; disability; congenital anomaly; requires intervention to prevent permanent impairment or damage
About this article
Cite this article
Bevacizumab/docetaxel. React. Wkly. 1428, 10 (2012). https://doi.org/10.2165/00128415-201214280-00031
- Breast Cancer
- Visual Acuity